Your transformation begins here
Lipotropic injections are generally not recommended during pregnancy or breastfeeding, for people with a known allergy to any component of the formulation (including B12/cobalt), for those with certain kidney or liver conditions, or for those with certain medical conditions
In pivotal TRIUMPH-1 Phase 3 trials, retatrutide showed remarkable promise, with participants experiencing an average weight loss of up to 28.3% after 80 weeks, making it potentially more effective than existing treatments like semaglutide (Wegovy) and tirzepatide (Zepbound)
FDA Concerns Surrounding Compounded GLP-1 In a May 16, 2025 statement, the U.S
Gradual Dose Administration: The recommended dosage schedule for Zepbound involves gradually increasing the dose over time: Initial dose : Start with 2.5 mg once a week for four weeks
Arora says that Foundayo is helpful for people who have varying schedules